Becotatug vedotin
Based on 1 Customer Validation
Becotatug vedotin (MRG003) is an Antibody-Drug Conjugate (ADC) that consists of an anti-EGFR humanized IgG1 monoclonal antibody Becotatug (HY-P990049) and MMAE (HY-15162). These two parts are connected through a valine-citrulline (valine-citrulline) linker, where the linker and MMAE constitute the ADC's Drug-Linker conjugate VcMMAE (HY-15575). Becotatug vedotin is also an inhibitor of tubulin, which can be used for the research of cancer, such as squamous cell carcinomas of the head and neck, nasopharyngeal carcinoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 96.99%
- Molecular Weight:149470 (average)
-
Speicherung:Shipping with dry ice
-80°C, protect from light
Biologische Aktivität
Beschreibung
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Product Details
Chemical Information
-
Appearance Liquid
-
Molecular Weight 149470 (average)
-
Color Colorless to light yellow
-
SMILES
[Becotatug vedotin]
-
Synonyms
MRG003
-
Versand
Shipping with dry ice.
-
Speicherung
-80°C, protect from light
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Becotatug vedotin
- MRG003
- MRG 003
- MRG-003
- Antibody-Drug Conjugates (ADCs)
- EGFR
- Antibody-Drug Conjugates
- ADC
- Epidermal growth factor receptor
- ErbB-1
- HER1
- monomethyl auristatin E
- nasopharyngeal carcinoma
- squamous cell carcinomas of the head and neck
- valine-citrulline linker
- epidermal growth factor receptor
- humanized immunoglobulin G1 monoclonal antibody
- Inhibitor
- inhibitor
- inhibit